CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2025-05-19 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-05-20 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-04 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-05 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2021-05-06 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +17,500 | 17,500 |
Page 1 of 1 · 6 trades